Form 4: Arbutus Biopharma Director Exercises and Sells Stock Options
SEC Form 4 Filing
Keith S. Manchester, a director at Arbutus Biopharma Corp, executed a cashless exercise of stock options and sold a portion of the underlying shares to cover the exercise price.
Summary
- On August 14, 2024, Keith S. Manchester, a director of Arbutus Biopharma Corp, exercised stock options.
- The exercise was cashless, meaning shares were sold to cover the exercise price.
- Manchester exercised options for 54,915 common shares at a price of $0.56 per share.
- He then sold 8,846 of these shares at $3.6895 per share to cover the exercise cost.
- Following the transaction, Manchester directly owns 46,069 common shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reflects a routine transaction of stock options nearing expiration.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.
Key Dates
| Date | Description |
|---|---|
| 08/14/2024 | Date of stock option exercise and sale of shares. |
| 11/13/2024 | Expiration date of the stock options. |
| 08/16/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.